ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2010

B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life Cohort

Amine Mouamnia, Armentieres Hospital Center, Armentieres, France

Meeting: ACR Convergence 2023

Keywords: Fracture, osteoporosis, pulmonary, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic obstructive pulmonary disease (COPD) is a chronic disease of the airways. It is mainly caused by smoking. Active smoking is a risk factor for osteoporosis. The occurrence of thoracic vertebral fractures can lead to additional deformities and ventilatory disorders. Moreover, little is known about the consequences of VF in COPD.

The objective is to determine the occurrence of vertebral fractures in a real-life COPD population hospitalized for exacerbation, and the risk factors involved.

Methods: The clinical characteristics of patients hospitalized in the pulmonology department from January 1 to December 31, 2022 were assessed. The diagnosis of vertebral fracture (VF) was assessed on standard chest X-rays.

Results: Of the 136 files analyzed, 106 patients were included. The main characteristics are shown in Table 1. The diagnosis of VF was largely underestimated (only 3.77% of VFs were described on standard chest X-rays). The prevalence of VF was 21.7%. The incidence rate was 23 cases per 106 patient-years. Lower BMI appears to be associated with the occurrence of VF p< 0.05. Patients with VF were hospitalized longer on average and had more exacerbations during the year, but this was not significant. There was no difference in mortality between the 2 groups.

Conclusion: VF are common in COPD patients, yet they remain under-diagnosed and may contribute to increased morbidity and mortality in this population over the long terme.

Supporting image 1

Table 1. Characteristics of patients


Disclosures: A. Mouamnia: None.

To cite this abstract in AMA style:

Mouamnia A. B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/b-frost-chronic-obstructive-pulmonary-disease-and-vertebral-fracture-of-osteoporotic-origin-results-of-a-real-life-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-frost-chronic-obstructive-pulmonary-disease-and-vertebral-fracture-of-osteoporotic-origin-results-of-a-real-life-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology